About 75% of all primary liver cancers in adults are HCC and up to 30% of HCC patients are eligible for embolisation
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim
The company has been ranked 8th on the list this year for three key attributes: ‘innovative leader in the industry’, ‘is socially responsible’ and ‘has loyal employees’
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
Genentech will be granted an exclusive license to develop and commercialize the degrader worldwide, and will be fully responsible for the development and commercialization costs.
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Subscribe To Our Newsletter & Stay Updated
